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Abstract
The mechanisms for the effect of hyperglycemia on insulin-induced mitogenesis were investigated using rat vascular
smooth muscle cells (VSMC). VSMC were preincubated in serum-free medium with low (5 mM) glucose (LG condition) or
high (25 mM) glucose (HG condition), and examined for DNA synthesis using bromodeoxyuridine (BrdUrd) incorporation.
Mitogen-activated protein kinase (MAPK) activity and MAPK phosphatase (MKP-1) protein expression were detected by
Western blot analysis. Phosphatidylinositol 3-kinase (PI-3K) activity was detected by thin layer chromatography. Insulin
induced a dose-dependent increase in BrdUrd incorporation (123.3 þ 2.6% over basal level with 1 WM insulin) in the LG
group and this effect was significantly enhanced (161.6 þ 10.4% over basal level) in the HG group. In the LG group, MAPK
activity was transient with a peak activation (137.4 þ 11.2% over basal level) after 10 min exposure to 100 nM insulin. In the
HG group, the MAPK activity was significantly potentiated (two-fold compared to the LG group) and was sustained even
after 60 min. Insulin also induced PI-3K activity and MKP-1 expression, both of which were blocked by the PI-3K inhibitor
wortmannin. In the HG group, insulin-induced PI-3K and MKP-1 expression was almost abolished. In conclusion, high
glucose enhances insulin-induced mitogenesis associated with the potentiation of insulin-stimulated MAPK activity in
VSMC. These effects of glucose might in part be due to the attenuation of MKP-1 expression through the blockage of the
insulin^PI-3K signal pathway. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
Insulin resistance and subsequent hyperinsulinemia
are closely associated with obesity, diabetes and hy-
pertension along with increased atherosclerotic vas-
cular risks such as coronary artery disease [1]. The
growth of vascular smooth muscle cells (VSMC)
plays a central role in the genesis of atherosclerosis
[2]. VSMC are responsive to insulin which experi-
mental studies have shown to be an atherogenic hor-
mone [3,4] ; the insulin stimulates the proliferation of
VSMC derived from humans and experimental ani-
mals [5,6].
Among the factors that induce insulin resistance,
hyperglycemia is important in attenuating the phys-
iological e¡ects of insulin in such areas as glucose
transport and metabolism [7,8], and a number of
investigations have described these e¡ects of hyper-
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glycemia [8^11]. Hyperglycemia induces the attenua-
tion of insulin receptor kinase activity downstream of
the receptor in several cell lines through the activa-
tion of protein kinase C and/or activation of phos-
photyrosine phosphatase (PTPase) [10,12]. Recent
studies suggest that hyperglycemia may also contrib-
ute to the abnormalities in VSMC through other
mechanisms including the induction of insulin resis-
tance. Elevated glucose enhances insulin-mediated
rat aortic smooth muscle cell migration and prolifer-
ation [9,11] although insulin-mediated glucose trans-
port is attenuated. Therefore, hyperglycemia associ-
ated with hyperinsulinemia could play an important
role in the pathogenesis of atherosclerosis in insulin
resistance. However, the mechanisms of glucose-
mediated modi¢cation of the insulin signaling path-
way are still unclear.
The intracellular mechanisms that mediate the mi-
togenic e¡ect of insulin have been intensively inves-
tigated for a decade [13]. The mitogen-activated pro-
tein kinase (MAPK) cascade is an important signal
system in mediating the mitogenic e¡ect of growth
factors including insulin [14]. Binding of insulin to its
speci¢c receptors induces a sequence of protein
kinase reactions, leading to activation of MAPK ki-
nase, MEK. MEK, the speci¢c activator of MAPK,
is a dual-speci¢city protein kinase that phosphory-
lates both threonine and tyrosine regulatory sites in
MAPK. Phosphorylated and activated MAPK mi-
grates to the nucleus, where it phosphorylates several
transcription factors; the extent of protein phosphor-
ylation is balanced by an antagonism of kinases and
phosphatase. MAPK phosphatase-1 (MKP-1), a
dual-speci¢c PTPase, has been de¢ned as an imme-
diate early gene, which rapidly induces its mRNA
and protein expression by growth factors including
insulin and dephosphorylates and inactivates MAPK
[15,16]. Recent studies reported that MKP-1 acts as a
negative regulator of the MAPK cascade in VSMC
[17^19].
We report here that high glucose attenuates insu-
lin-induced MKP-1 expression in VSMC. Insulin-
stimulated MAPK activity is enhanced and sustained
in the presence of high glucose, and the mitogenic
e¡ects of insulin are also enhanced. Our ¢ndings
provide new insight into the mechanisms of glu-
cose-mediated modi¢cation of insulin action in
VSMC.
2. Materials and methods
2.1. Materials
Dulbecco’s modi¢ed Eagle’s medium (DMEM)
and fetal bovine serum (FBS) were obtained from
Gibco-BRL. Antibodies to p44/42 MAP kinase and
its phosphospeci¢c MAPK (Thr202, Tyr204) were
obtained from New England BioLabs, and anti-
MKP-1 antibody was obtained from Santa Cruz Bio-
technology. Cell Proliferation ELISA kit was pur-
chased from Boehringer Mannheim.
2.2. Cell culture
Rat aortic VSMC were isolated, as previously de-
scribed [20], from medial explants of the thoracic
aorta of male Sprague^Dawley rats (6^7 weeks
old). VSMC were grown to con£uence in DMEM
containing 5 mM glucose, 10% FBS and 100 IU/ml
penicillin and 100 Wg/ml streptomycin. For the ex-
periments, subculture cells from passages 4^8 at
about 80% con£uence in culture were used.
2.3. Bromodeoxyuridine incorporation
Cells were cultured on 96-well plates, and made
quiescent by serum deprivation for 24 h in DMEM
containing 0.05% bovine serum albumin instead of
serum and indicated concentrations of glucose. The
cells were then incubated for a further 24 h with or
without insulin (1^10 000 nM). The last 4 h of this
incubation period was carried out in the presence of
0.5 WM 5-bromo-2P-deoxyuridine (BrdUrd). BrdUrd
incorporation was determined by ELISA, visualized,
and quanti¢ed by colorimetry.
2.4. Western blot analysis
Serum-starved cells grown on 6-well plates were
preincubated with the indicated concentration of glu-
cose, then exposed to insulin (1^1000 nM) for 0^60
min. The reaction was terminated by replacement of
medium with a lysis bu¡er (20 mM Tris^HCl (pH
7.5), 150 mM NaCl, 10% glycerol, 1 mM EGTA,
100 WM dithiothreitol, 2 mM sodium orthovanadate,
5 mM sodium pyrophosphate and 1 mM phenyl-
methylsulfonyl £uoride, 5 U/ml egg white trypsin
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inhibitor, 10 Wg/ml leupeptin). The cells were homog-
enized by brief sonication, and centrifuged at
12 000Ug for 20 min at 4‡C. The protein concentra-
tions were determined using the Bradford protein
assay [21]. Equal amounts of protein (5^10 Wg)
were subjected to sodium dodecyl sulfate polyacryl-
amide gel electrophoresis and Western blot analysis
was performed using anti-phosphospeci¢c p44/42
MAPK and total p44/42 MAPK antibodies. Relative
intensity of phospho-MAPK to total MAPK was
quanti¢ed by densitometry.
2.5. Immunoprecipitation
Serum-starved VSMC on 100-mm dishes were ex-
posed to insulin (100 nM) for 0^60 min. Then, the
cells were washed with ice-cold phosphate-bu¡ered
saline and resuspended in lysis bu¡er containing
1% Triton X-100 followed by homogenization by
brief sonication. The sample was centrifuged at
12 000Ug for 20 min at 4‡C. After the protein con-
tent in resting supernatants was normalized, the sam-
ple was incubated with anti-MKP-1 antibody for 4^6
h at 4‡C. Immunocomplexes were absorbed to pro-
tein A-agarose (Sigma Chemical Co.) and washed
three times with lysis bu¡er. The immunoprecipitants
were resolved by the addition of 1ULaemmli bu¡er
and MKP-1 protein was detected by Western blot
analysis as described above. The intensity of MKP-
1 protein was quanti¢ed by densitometry.
2.6. Phosphatidylinositol 3-kinase (PI-3K) assay
Immunoprecipitation was performed using anti-in-
sulin-receptor substrate-1 (IRS-1) antibody as de-
scribed above except for the detergent, 1% Nonidet
p40 in lysis bu¡er. PI-3K activity was measured as
described previously with slight modi¢cations [19].
Brie£y, the agarose-bound immunocomplexes were
resuspended in 30 Wl of reaction bu¡er (in mM:
20 Tris^HCl, pH 7.5, 10 MgCl2, 1 dithiothreitol
and 0.2 mg/ml phosphatidylinositol). The reaction
was initiated by addition of ATP solution (25 WM
[Q-32P]ATP (about 10 WCi)). After incubation for
10 min at 25‡C, the products were analyzed by thin
layer chromatography on silica gel plates (K6, What-
man) followed by visualization of the spots by auto-
radiography.
2.7. Statistical analysis
Data were analyzed by Student’s paired or un-
paired t-test with a P value of less than 0.05 being
considered signi¢cant.
3. Results
3.1. E¡ects of glucose on insulin-mediated DNA
synthesis
Quiescent VSMC in a low glucose (5 mM) condi-
tion (LG group) were exposed to increasing concen-
trations of insulin, and DNA synthesis assessed by
BrdUrd incorporation was measured 24 h after stim-
ulus. Insulin stimulated BrdUrd incorporation in a
dose-dependent manner. In the LG group, insulin at
physiological concentration levels (from 10 nM to
1 WM) stimulated DNA synthesis (Fig. 1). Insulin-
induced BrdUrd incorporation in the high glucose
Fig. 1. E¡ects of glucose on insulin-mediated DNA synthesis in
VSMC. Cells were serum-starved in the presence of 5 mM glu-
cose (a) or 25 mM glucose (b), then incubated with the indi-
cated concentrations of insulin for 24 h. BrdUrd incorporation
was determined by colorimetry as described in Section 2. Re-
sults represent the mean þ S.E.M. of BrdUrd incorporation as a
percent above basal level which is de¢ned as 100% (n = 10;
*P6 0.05, **P6 0.01 vs. basal value, #P6 0.05 vs. low glucose
group).
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(25 mM) group (HG group) was signi¢cantly higher
than that in the LG group (Fig. 1). Glucose en-
hanced insulin-induced DNA synthesis in a glucose
concentration (from 5 to 25 mM)-dependent manner,
with maximal enhancement being reached at 25 mM
D-glucose (Fig. 2); thus, a glucose concentration of
25 mM was used for further experiments.
The MAPK signaling cascade is an important sys-
tem in mediating the mitogenic e¡ect of insulin [14].
To examine the role of the MAPK signaling pathway
on insulin-induced DNA synthesis, we used the
MEK-speci¢c inhibitor PD98059. The cells were pre-
incubated with low (5 mM) or high (25 mM) glucose,
and treated with 50 WM PD98059 prior to exposure
to insulin. PD98059 inhibited insulin-induced
BrdUrd incorporation in both low and high glucose
conditions (Fig. 2).
3.2. E¡ects of glucose on insulin-mediated MAPK
activity
It is possible that glucose may enhance the e¡ects
of insulin on the MAPK signaling cascade corre-
Fig. 2. Dose response of glucose on DNA synthesis in VSMC.
Cells were serum-starved in the presence of the indicated con-
centrations of glucose for 24 h, followed by incubation with
100 nM insulin (hatched bars) or without (open bars) for
10 min. In some experiments, cells were pretreated with 50 WM
PD98059 prior to exposure to insulin (closed bars). BrdUrd in-
corporation in VSMC was determined as described in Section
2. Results represent the mean þ S.E.M. of BrdUrd incorporation
as a percent above basal level (n = 9; *P6 0.05, **P6 0.01).
Fig. 3. E¡ects of glucose on insulin-induced MAPK activity in
VSMC. VSMC were pretreated with 25 mM glucose (b) or
without (a) for 24 h and stimulated with the indicated doses of
insulin for the indicated times. Phosphorylated MAPK and to-
tal proteins were detected by Western blot analysis as described
in Section 2. Data are expressed as fold MAPK activity, in
which phospho-MAPK in unstimulated cells is de¢ned as 100%.
The data shown represent mean þ S.E.M. from seven separate
experiments (*P6 0.05, **P6 0.01 vs. basal value, #P6 0.05
vs. low glucose group). (A) Dose^response curve of insulin on
MAPK activation in VSMC. (B) Time course of 100 nM insu-
lin-stimulated MAPK activity. Western blot represents phos-
pho-MAPK from single representative experiments.
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sponding to the stimulated mitogenic e¡ects in the
presence of high glucose. To examine the in£uence of
glucose on insulin-mediated MAPK activity, the cells
were pretreated with 25 mM glucose (HG group) or
5 mM (LG group) for 24 h then incubated with
100 nM insulin for indicated times, and MAPK ac-
tivities were estimated by Western blot analysis using
anti-phosphospeci¢c MAPK antibody. As shown in
Fig. 3, in both LG and HG groups, phosphorylation
of MAPK was increased in a dose- and time-depen-
dent manner with similar ED50s (about 10 nM). The
peak level of MAPK activity in the HG group was
signi¢cantly enhanced compared to that in the LG
group (Fig. 3B). Rapid inactivation of MAPK en-
sued with a return to the basal level after 30 min
of exposure of insulin in the LG group. In contrast,
the activity was sustained up to 60 min in the HG
group (Fig. 3A).
3.3. E¡ects of glucose on insulin-induced MKP-1
activity
Recently, it has been demonstrated that MKP-1
dephosphorylates and inactivates MAPK and plays
a role in the compensatory inactivation of MAPK
signaling pathways [16,17,19]. To further understand
the mechanism of enhanced insulin-induced MAPK
activation in the presence of high glucose, we exam-
ined the extent of MKP-1 induction in response to
insulin. Quiescent VSMC, which were pretreated
with 25 mM glucose (HG group) or 5 mM (LG
group) for 24 h, were exposed to 100 nM insulin
for the indicated times and protein extracts were pre-
pared. Equal amounts of proteins were used to test
MKP-1 protein induction using Western blot analy-
sis. As shown in Fig. 4, in the LG group, exposure of
cells to insulin resulted in a time-dependent induction
of MKP-1, which was evident at 10 min and reached
a maximum after 60 min incubation. In the HG
group, although the basal MKP-1 level was not al-
tered, insulin-induced MKP-1 expression was almost
abolished during the 60 min incubation (Fig. 4).
3.4. E¡ects of glucose on insulin-induced PI-3K
activity in VSMC
PI-3K is an important mediator for physiological
functions of insulin [13,22]. It has been reported that
hyperglycemia attenuates insulin receptor kinase ac-
tivity, resulting in inhibition of the activities of IRS-1
and PI-3K in several cell types [12,23]. We tested the
in£uence of glucose on insulin-induced PI-3K activ-
ity in VSMC. As shown in Fig. 5, insulin stimulated
PI-3K activity in both LG and HG conditions. How-
ever, in the HG condition, the PI-3K activity was
signi¢cantly attenuated compared to that in the LG
condition.
3.5. Role of PI-3K and MEK inhibitors on insulin-
induced MKP-1 expression in VSMC
To examine the mechanisms of the inhibitory e¡ect
of glucose on MKP-1 induction, we tested the role of
the PI-3K-speci¢c inhibitor wortmannin on insulin-
mediated MKP-1 induction. The cells were preincu-
bated with 5 WM wortmannin for 20 min prior to
exposure to insulin. As with high concentrations of
Fig. 4. E¡ects of glucose on insulin-induced MKP-1 expression
in VSMC. VSMC were serum-starved with or without 25 mM
glucose for 24 h and stimulated with 100 nM insulin for the in-
dicated times. Expressed MKP-1 in the same amount of cell ex-
tracts was detected by Western blot analysis as described in
Section 2. Data are expressed as fold MKP-1 expression, in
which MKP-1 in unstimulated cells (basal level) is de¢ned as
100%. Each value shown represents mean þ S.E.M. from nine
separate experiments (**P6 0.01 vs. basal value, ##P6 0.01 vs.
low glucose group). Western blot represents MKP-1 from single
representative experiments.
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glucose, wortmannin signi¢cantly inhibited insulin-
mediated MKP-1 expression (Fig. 6). Previous stud-
ies in di¡erent cell types suggest that MKP-1 induc-
tion may be regulated by MAPK [19,24]. Therefore,
to evaluate the potential contribution of the MAPK
signaling pathway in insulin-induced MKP-1 expres-
sion, we used the MAPK kinase inhibitor PD98059.
The cells were pretreated with PD98059 for 20 min
followed by insulin exposure. Insulin-induced MKP-
1 expression was partially blocked by PD98059, sug-
gesting that p44/46 MAPK contributes in part to
insulin-induced MKP-1 induction (Fig. 6).
4. Discussion
We showed that high glucose weakly induced
DNA synthesis and, in addition, synergistically
stimulated the insulin-induced mitogenic e¡ect in
VSMC. Thus, high glucose levels might somehow
a¡ect the intracellular signaling pathway of insulin,
resulting in a modi¢cation of the insulin-induced mi-
togenic e¡ect. Recently, it has been demonstrated
that high glucose modi¢es the mitogenic e¡ects of
several growth factors; under high glucose condi-
tions, insulin stimulated 12-hydroxyeicosatetraenoic
acid-induced migration of rat aortic SMC [9]. Re-
cently, Yasunari et al. reported that high glucose
treatment increases platelet-derived growth factor
(PDGF)-mediated migration and even insulin-in-
duced DNA synthesis in rabbit coronary SMC [11].
Numerous studies have investigated the molecular
mechanisms of the e¡ects of hyperglycemia. Hyper-
glycemia stimulates sorbitol pathway metabolism
and increases the ratio of NADH/NAD [25] and
hyperglycemia-induced metabolic imbalances cause
the production of several factors: diacylglycerol,
which is known as protein kinase C activator, free
radicals, and superoxide.
Fig. 6. E¡ects of wortmannin and PD98059 on insulin-induced
MKP-1 expression in VSMC. VSMC were serum-starved with
or without 25 mM glucose for 24 h, and pretreated with
100 nM wortmannin or 50 WM PD98059 just 20 min prior to
exposure to 100 nM insulin. After 60 min incubation, expressed
MKP-1 in the same amount of cell extract was detected by
Western blot analysis as described in Section 2. Data are ex-
pressed as fold MKP-1 expression, in which MKP-1 in unstim-
ulated cells (basal level) is de¢ned as 100%. Each value shown
represents mean þ S.E.M. from 10 separate experiments
(**P6 0.01).
Fig. 5. E¡ects of glucose on insulin-induced PI-3K activity.
VSMC were incubated with serum-free medium containing low
(5 mM) or high glucose (25 mM) for 24 h and stimulated with
100 nM insulin (hatched bars) or without (open bars). PI-3K
activities in the same amount of cell extract were detected as
described in Section 2. Data are expressed as fold PI-3K activ-
ity, in which PI-3K in unstimulated cells with low glucose is de-
¢ned as 100%. Each value shown represents mean þ S.E.M.
from four separate experiments (*P6 0.05, **P6 0.01).
BBAMCR 14637 6-7-00
N. Takehara et al. / Biochimica et Biophysica Acta 1497 (2000) 244^252 249
MAPK activation results in the activation of
downstream transcriptional factors such as c-jun
and fos that are required for cell proliferation [26].
MAPK has been implicated in insulin-induced
growth e¡ects [13]. In the present study, under high
glucose conditions, enhanced MAPK activity is
strongly associated with potentiation of insulin-in-
duced DNA synthesis in VSMC (Figs. 1 and 3). In-
deed, the MAPK kinase inhibitor PD98059 blocked
insulin-induced DNA synthesis (Fig. 2). These data
emphasize the importance of the mechanisms to reg-
ulate the activity of MAPK for the mitogenesis of
VSMC in the presence of high glucose. The enhanced
MAPK activation could have resulted from a de-
crease in the activity of tyrosine phosphatase and
an increase in the activity of upstream participants
in the ras/raf/MAPK kinase signaling cascade. Re-
cent studies have demonstrated that MKP-1 is an
important candidate phosphatase for the negative
regulation on mitogen-induced MAPK activity
[17,18]. In this study, insulin induced MKP-1 expres-
sion simultaneously with the activation of MAPK in
VSMC, suggesting that MKP-1 plays a role in inac-
tivation of MAPK. We also clearly showed that high
glucose signi¢cantly inhibits insulin-induced MKP-1
expression. Therefore, these data suggest that sus-
tained MAPK activity might result from the attenu-
ation of insulin-induced MKP-1 expression under
high glucose conditions.
Insulin activates the intrinsic tyrosine kinase activ-
ity of its receptor resulting in the phosphorylation of
substrates such as IRS-1 [13]. These proteins act as
docking molecules for other proteins via the SH2
domain, leading to the stimulation of PI-3K and
the ras/raf/MAPK cascade. Recently, Begum et al.
[19] reported that blockade of PI-3K signaling with
its speci¢c inhibitor wortmannin inhibited insulin-
mediated nitric oxide synthase protein induction
and subsequently MKP-1 expression, suggesting
that insulin-induced MKP-1 expression is mediated
by PI-3K-initiated signaling in VSMC. It is known
that hyperglycemia induces insulin resistance, attenu-
ating its receptor kinase activity, and subsequent de-
crease in IRS-1 phosphorylation [12]. We also found
that insulin-stimulated PI-3K activities in VSMC are
attenuated under high glucose conditions (Fig. 5). In
this study, wortmannin blocked insulin-induced
MKP-1 expression, an e¡ect similar to that under
high glucose conditions (Fig. 6). Together, these
data suggest that insulin mediates MKP-1 expression
through the PI-3K signaling pathway, and high glu-
cose attenuates insulin-induced MKP-1 expression as
a result of attenuation of PI-3K activation.
We showed in Fig. 6 that insulin-induced MKP-1
expression was partially blocked by PD98059. This is
in agreement with a previous ¢nding that p44/46
MAPK regulates in part insulin-induced MKP-1 in-
duction [19,24]. Interestingly, we also showed that
insulin-induced MKP-1 expression was attenuated
whereas MAPK activity was increased in the pres-
ence of high glucose. It is not clear how to explain
this discrepancy of high MAPK activity with low
MKP-1 expression in high glucose conditions. How-
ever, a previous study has reported that VSMC from
spontaneously hypertensive rats have a potent mito-
genic response to insulin, associated with increased
MAPK activity and impaired MKP-1 expression
[27]. Recently, more complicated mechanisms of ag-
onist-induced MKP-1 expression have been sug-
gested. In VSMC, an induction of MKP-1 expression
is mediated not only through the MAPK pathway
but also through the stress-activated protein kinase
(SAPK) and p38 MAPK pathways [24]. Moreover,
arachidonic acid-induced MKP-1 expression in
VSMC is mediated through tyrosine kinase [28].
The above ¢ndings suggest the existence of a com-
plex cross-talk between the ERK/SAPK and p38
MAPK and even unidenti¢ed signaling pathways.
The exact mechanisms how insulin-induced MKP-1
expression is altered in the presence of high glucose
remain to be clari¢ed.
Peak MAPK activity was reached at 10 min incu-
bation with insulin, whereas MKP-1 was not signi¢-
cantly expressed (Figs. 3 and 4). In addition, basal
MKP-1 protein in VSMC was not changed by high
glucose. Therefore, enhanced peak MAPK activity in
the high glucose condition does not account for the
attenuation of MKP-1 expression. These data sug-
gest that the enhanced peak activity of MAPK could
result from the increase in the upstream MAPK cas-
cade. Although the mechanisms by which high glu-
cose stimulates upstream of the MAPK cascade are
not yet clear, there are some candidate target pro-
teins. Because insulin-induced IRS-1 and PI-3K are
attenuated under high glucose conditions, an IRS-1-
independent pathway such as the Shc/Grb/ras/raf
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cascade should be present to mediate MAPK activa-
tion. The mechanisms by which high glucose stimu-
lates upstream of the MAPK cascade have yet to be
clari¢ed.
In summary, we demonstrated that high glucose
attenuated insulin-induced MKP-1 expression, which
acts as a negative player in the MAPK cascade, re-
sulting in sustained MAPK activity in VSMC. These
results suggest that attenuation of MKP-1 expression
may be the key mechanism for the increased VSMC
growth potential of insulin under high glucose con-
ditions.
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